These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10588305)

  • 1. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
    Totsuka K; Shiseki M; Kikuchi K; Matsui Y
    J Antimicrob Chemother; 1999 Oct; 44(4):455-60. PubMed ID: 10588305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus.
    Oka S; Goto M; Kaji Y; Kimura S; Matsuda K; Asahi Y; Sanada M; Nakagawa S; Inoue M; Shimada K
    J Antimicrob Chemother; 1993 Apr; 31(4):533-41. PubMed ID: 8514648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
    Nagano R; Shibata K; Naito T; Fuse A; Asano K; Hashizume T; Nakagawa S
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2278-81. PubMed ID: 9333062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
    Chandrasekar PH; Levine DP; Price S; Rybak MJ
    J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
    Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots.
    Palmer SM; Rybak MJ
    J Antimicrob Chemother; 1997 Apr; 39(4):515-8. PubMed ID: 9145825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro.
    Chang SC; Hsieh WC; Luh KT; Ho SW
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):488-92. PubMed ID: 2794948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
    Kouda M
    Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Lozniewski A; Lion C; Mory F; Weber M
    J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.
    Rochon-Edouard S; Pestel-Caron M; Lemeland JF; Caron F
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3055-60. PubMed ID: 11036022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
    Kang SL; Rybak MJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus.
    Schaad HJ; Chuard C; Vaudaux P; Rohner P; Waldvogel FA; Lew DP
    J Antimicrob Chemother; 1994 Jun; 33(6):1191-200. PubMed ID: 7928812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. I. Synergistic actions of cefotiam with imipenem and vancomycin].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Feb; 46(2):115-22. PubMed ID: 8331771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
    Matsuda K; Asahi Y; Sanada M; Nakagawa S; Tanaka N; Inoue M
    J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
    Barr JG; Smyth ET; Hogg GM
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Navas D; Batard E; Miegeville AF; Le Mabecque V; Kergueris MF; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Jan; 49(1):45-51. PubMed ID: 15616274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.